Table 2 Demographics and clinical characteristics of Parkinson’s disease patients in two subtypes
From: Identifying brain degeneration patterns in early-stage Parkinson’s disease: a multimodal MRI study
Subtype1 | Subtype2 | |||
|---|---|---|---|---|
Variable | (n = 72) | (n = 107) | p value | Adj.p |
Demographics | ||||
Age, years | 63.86 ± 7.44 | 51.99 ± 9.59 | <0.001 | / |
Sex, male | 32 (44.44%) | 68 (63.55%) | <0.001 | / |
Education, years | 6.00 (6.80) | 9.00 (5.00) | <0.001 | / |
Disease duration, years | 1.82 (1.59) | 1.64 (2.28) | 0.365 | / |
HY stage | 2.12 ± 0.49 | 1.86 ± 0.50 | 0.535 | / |
Motor symptoms | ||||
UPDRS-II | 9.08 ± 4.93 | 6.05 ± 4.10 | 0.009 | 0.047 |
UPDRS-III | 25.39 ± 12.88 | 16.93 ± 9.61 | 0.012 | 0.047 |
Tremor scores | 4.43 ± 3.90 | 3.58 ± 2.89 | 0.382 | 0.412 |
Rigidity scores | 6.32 ± 5.61 | 4.30 ± 3.40 | 0.041 | 0.075 |
Bradykinesia scores | 12.10 ± 7.81 | 7.80 ± 5.81 | 0.019 | 0.047 |
Cognitive assessment | ||||
MMSE scores | 24.71 ± 4.17 | 27.43 ± 3.48 | 0.020 | 0.047 |
AVLT long delayed recall | 3.33 ± 2.80 | 4.73 ± 2.78 | 0.265 | 0.309 |
SFT-Animal Naming | 12.69 ± 4.10 | 15.68 ± 5.01 | 0.194 | 0.247 |
DST (total) | 10.79 ± 2.29 | 11.97 ± 2.86 | 0.061 | 0.095 |
SDMT (correct) | 25.55 ± 12.64 | 39.59 ± 13.76 | 0.003 | 0.023 |
Other Non-Motor symptoms | ||||
GDS | 3.42 ± 3.19 | 2.22 ± 2.66 | 0.013 | 0.047 |
RBDQ-HK (total) | 19.08 ± 15.47 | 13.88 ± 12.26 | 0.847 | 0.847 |
PDQ-39 | 21.58 ± 19.76 | 13.01 ± 14.52 | 0.078 | 0.110 |
SCOPA-AUT | 9.93 ± 7.08 | 5.61 ± 4.98 | 0.043 | 0.075 |